A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
Status:
RECRUITING
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability and pharmacokinetics and pharmacodynamics of oral doses of FB418 in healthy adult subjects and healthy elderly subjects.